$56.90
+0.41 (+0.73%)
Open$56.38
Previous Close$56.49
Day High$57.17
Day Low$56.25
52W High$55.16
52W Low$13.95
Volume—
Avg Volume976.4K
Market Cap2.81B
P/E Ratio25.31
EPS$2.07
SectorBiotechnology
Analyst Ratings
Buy
13 analysts
Price Target
-12.5% upside
Current
$56.90
$56.90
Target
$49.81
$49.81
$29.15
$49.81 avg
$64.16
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 370.03M | 350.14M | 329.37M |
| Net Income | -20,802,666 | -17,716,123 | -60,795,749 |
| Profit Margin | -5.6% | -5.3% | -18.5% |
| EBITDA | -27,453,082 | -24,678,678 | -79,903,104 |
| Free Cash Flow | — | — | -60,969,564 |
| Rev Growth | +5.7% | +5.7% | -9.3% |
| Debt/Equity | — | — | 0.76 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.99 | -0.08% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $406.46 | -0.92% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.37 | -1.51% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $799.26 | -0.58% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $246.45 | -2.07% | 40.0 | 32.33B |